Receive our newsletter – data, insights and analysis delivered to you
  1. News
February 24, 2020updated 25 Feb 2020 9:15am

Animal testing begins for first novel coronavirus vaccines in China

The initial recombinant protein vaccines have produced antibodies during preclinical testing in mice, said Zhejiang Science and Technology department official at a press conference.


Visit our Covid-19 microsite for the latest coronavirus news, analysis and updates


Follow the latest updates of the outbreak on our timeline.

The initial recombinant protein vaccines have produced antibodies during preclinical testing in mice, said Zhejiang Science and Technology department official at a press conference.

The department’s deputy director Song Zhiheng added that mRNA vaccines have also advanced into the animal experiment stage.

Animal testing for recombinant adenovirus vector vaccines could be initiated soon, while virus strains selection has progressed into the fourth generation.

Commenting on the progress, Song said: “At present, researchers are racing against the clock and working hard to overcome difficulties.

“But it is also important to realise that due to the relatively long period of vaccine development, scientific laws must be respected and a scientific, rigorous and safe research process must be followed.

Earlier this month, Imperial College London researchers in the UK started animal testing a novel coronavirus vaccine. This announcement was followed by the progress of Serum Institute of India and Codagenix’s vaccine candidate into preclinical phase.


See all Coronavirus vaccines and drugs in the pipeline


At a meeting held on 11 and 12 February in Geneva, World Health Organization (WHO) director-general Dr Tedros Adhanom Ghebreyesus said that a vaccine for the novel coronavirus may be available in 18 months.

Related Companies

Topics in this article:
NEWSLETTER Sign up Tick the boxes of the newsletters you would like to receive. A weekly roundup of the latest news and analysis, sent every Friday. The pharmaceutical industry's most comprehensive news and information delivered every month.
I consent to GlobalData UK Limited collecting my details provided via this form in accordance with the Privacy Policy
SUBSCRIBED

THANK YOU